Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
Despite the economic downturn, UK life sciences companies raised a healthy £382 million ($486 million) in new financing in the second quarter of the year, with venture cap
The UK government has formally opened a state-of-the-art vaccine research facility based at the UK Health and Security Agency (UKHSA) to improve the country's preparedness
The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company
Biogen and Sage Therapeutics' zuranolone has become the first oral drug to be approved by the FDA for post-partum depression (PPD), but the US regulator turned down a requ
Many articles on artificial intelligence (AI) promise amazing results, tons of money, and thousands of new clients, all thanks to the magical tool.
Among various challenges, living with a rare condition can be quite lonely.
Every marketer and sales representative shares a common desire: to achieve more with less effort.
The top global KOLs in a therapy area might offer some insight into HCP behaviour in their geographies, but to understand the national and local challenges in a target region, you’ll need c
Expedite LNP Applications for Next Generation Therapeutics beyond mRNA with Optimised Formulation, Scalability & Regulatory Compliance at Forefront of Mind